Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 19% ± 3% | |
| epithelial cell | 6 studies | 28% ± 11% | |
| classical monocyte | 3 studies | 19% ± 1% | |
| GABAergic neuron | 3 studies | 29% ± 4% | |
| glutamatergic neuron | 3 studies | 34% ± 5% | |
| dendritic cell | 3 studies | 21% ± 4% | |
| macrophage | 3 studies | 20% ± 2% | |
| astrocyte | 3 studies | 26% ± 3% | |
| oligodendrocyte | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2793.28 | 1445 / 1445 | 100% | 22.36 | 183 / 183 |
| uterus | 100% | 2745.86 | 170 / 170 | 100% | 17.77 | 459 / 459 |
| brain | 100% | 1707.48 | 2640 / 2642 | 100% | 16.54 | 705 / 705 |
| lung | 100% | 2655.81 | 578 / 578 | 100% | 18.76 | 1154 / 1155 |
| thymus | 100% | 2650.98 | 653 / 653 | 100% | 15.53 | 604 / 605 |
| breast | 100% | 2384.67 | 459 / 459 | 100% | 20.57 | 1116 / 1118 |
| prostate | 100% | 2473.73 | 245 / 245 | 100% | 16.47 | 501 / 502 |
| stomach | 100% | 2029.09 | 359 / 359 | 100% | 16.22 | 285 / 286 |
| ovary | 100% | 2237.47 | 180 / 180 | 100% | 11.50 | 428 / 430 |
| intestine | 100% | 2589.61 | 966 / 966 | 99% | 16.30 | 524 / 527 |
| pancreas | 100% | 1532.03 | 327 / 328 | 99% | 13.97 | 177 / 178 |
| bladder | 100% | 2718.19 | 21 / 21 | 99% | 15.80 | 499 / 504 |
| skin | 100% | 3299.04 | 1808 / 1809 | 98% | 17.79 | 463 / 472 |
| kidney | 100% | 1618.71 | 89 / 89 | 97% | 9.85 | 876 / 901 |
| adrenal gland | 100% | 3264.07 | 258 / 258 | 97% | 11.92 | 223 / 230 |
| liver | 100% | 1534.57 | 226 / 226 | 97% | 7.54 | 392 / 406 |
| adipose | 100% | 2557.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2585.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.88 | 29 / 29 |
| muscle | 100% | 3536.00 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2783.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.79 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.09 | 1 / 1 |
| heart | 98% | 1732.30 | 845 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 91% | 2402.52 | 845 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 84% | 7.85 | 67 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006398 | Biological process | mRNA 3'-end processing by stem-loop binding and cleavage |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005847 | Cellular component | mRNA cleavage and polyadenylation specificity factor complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0098794 | Cellular component | postsynapse |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | CPSF2 |
| Protein name | Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit) Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) |
| Synonyms | CPSF100 KIAA1367 |
| Description | FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that play a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Involved in the histone 3' end pre-mRNA processing. . |
| Accessions | G3V5T3 G3V3T7 Q9P2I0 ENST00000553427.5 ENST00000554290.1 ENST00000555244.1 H0YJF4 ENST00000298875.9 |
